Stephen Saklad, Pharm.D., BCPP

Financial relationships

  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    Alkermes
    Topic:
    Psychotropics
    Date added:
    08/15/2024
    Date updated:
    08/15/2024
  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    BMS
    Topic:
    Psychotropics
    Date added:
    08/15/2024
    Date updated:
    08/15/2024
  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    Genomind
    Topic:
    Pharmacogenomics
    Date added:
    08/15/2024
    Date updated:
    08/15/2024
  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    Janssen
    Topic:
    Psychotropics
    Date added:
    08/15/2024
    Date updated:
    08/15/2024
  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    Lundbeck
    Topic:
    Psychotropics
    Date added:
    08/15/2024
    Date updated:
    08/15/2024
  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    Otsuka
    Topic:
    Psychotropics
    Date added:
    08/15/2024
    Date updated:
    08/15/2024
  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    Neurocrine
    Topic:
    Psychotropics
    Date added:
    08/15/2024
    Date updated:
    08/15/2024
  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    Teva
    Topic:
    Psychotropics
    Date added:
    08/15/2024
    Date updated:
    08/15/2024
Return to ECHO Behavioral Health in Primary Care: New Psychiatric Medications - 11/20/2024